By Charles Miller, CRNA, CMO, Founder/Owner of Scenic City Neurotherapy
Ever wonder, “how does hetamine work in the brain?” Research shows that ketamine opens a temporary window in which the brain becomes more responsive to meaningful change. This process, known as neuroplasticity, allows the brain to restore and reorganize neural connections. Unlike traditional antidepressants that work gradually over time, ketamine initiates a rapid cascade of activity, with measurable changes often occurring within 24–48 hours.
At Scenic City Neurotherapy, ketamine is administered in a medically supervised setting as part of a structured, evidence-based protocol informed by research from leading institutions.
Ketamine has been studied for its effects on brain communication. Rather than simply changing mood, research suggests it influences how brain cells connect and relay information in brain regions involved in thinking, emotional regulation, and stress response. This involves the following series of events:
Research has associated greater dendritic complexity with:
Watch a short video explanation featuring Charles Miller from Scenic City Neurotherapy.
Research has documented that prolonged stress and emotional strain are associated with changes in dendritic structure. Over time, this may include reduced dendritic density and complexity, which is described in the literature as dendritic regression.
Changes in connectivity have been associated with:
This research on brain connectivity helps establish the scientific premise for the services offered at Scenic City Neurotherapy.
Ketamine is studied for its association with neuroplasticity, the brain’s capacity to adapt and reorganize how it communicates. In research settings, ketamine is described as influencing:
At Scenic City Neurotherapy, this understanding of brain connectivity and plasticity guides how our treatment approach is structured. Treatment is not framed as an experience or a mood intervention, but as a way to support the brain’s capacity to develop healthier, more adaptive communication patterns over time.
Changes in brain communication are often discussed in terms of functional indicators. In other words, observable patterns related to an individual’s thoughts, feelings, and behaviors over time.
At Scenic City Neurotherapy, these indicators are viewed as markers of brain-level functioning and are monitored longitudinally rather than evaluated based on a single infusion.
Ketamine is sometimes grouped with psychedelics, but it is more accurately described as a psychoplastogen, a compound that promotes rapid neural plasticity through a distinct biological pathway.
(e.g., Psilocybin, LSD, DMT)
Understanding how ketamine differs from classic psychedelics helps set realistic expectations for the treatment. While classic psychedelics tend to produce their main effects during administration, ketamine works in a different way. Its effects are less about what happens in the infusion and more about how brain connections change in the days and weeks that follow.
Not everyone experiences dramatic perceptual effects during ketamine treatment. At Scenic City Neurotherapy, clinical benefit does not depend on feeling dissociated or having a hallucinogenic-type experience. Science supports the therapeutic effect is linked to what happens in the brain 24-48 hours after the infusion.
At Scenic City Neurotherapy, our MSKIT® protocol emphasizes post-stabilization support, recognizing that ketamine is typically considered within a broader, ongoing care framework.
Research suggests that ketamine’s benefits depend not only on the drug itself, but on how care is structured around the brain’s increase in neuroplasticity. At Scenic City Neurotherapy, this is reflected in three practical elements: timing, support, and follow-up.
This approach helps set clear expectations about the role of the treatment while emphasizing the importance of patient engagement outside the clinical setting.
Some patients notice subtle shifts within hours, while others begin to feel meaningful change gradually throughout the Stabilization Phase and beyond. There’s no standardized timeline, as individual responses naturally differ. Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) opens the door for change, and your ongoing work helps guide how that change takes shape.
Yes. Ketamine is considered very safe for treating depression when it’s administered at low, controlled doses by trained medical professionals. Unlike many anesthetics, ketamine does not suppress breathing or heart function, and it has been safely used in medicine since the 1970s.
At Scenic City Neurotherapy, ketamine is delivered intravenously by a Certified Registered Nurse Anesthetist in a monitored medical setting with private treatment rooms, continuous vital-sign tracking, and individualized dosing based on your needs.
Research shows that IV ketamine produces more reliable and longer-lasting effects than at-home oral ketamine. IV delivery provides 100% bioavailability, precise dosing, and medical supervision, resulting in more consistent activation of ketamine’s neuroplastic effects.
In contrast, oral at-home ketamine has lower and more variable absorption, less predictable dosing, and limited supporting evidence. Because of this, it does not replicate the neurobiological impact seen with medically supervised IV treatment.
Ketamine is studied for how it relates to flexibility and communication of brain circuits that are commonly affected by prolonged periods of stress and adaptation. This perspective moves the conversation beyond the infusion experience and toward tracking functional indicators associated with brain-level processes over time.
At Scenic City Neurotherapy in Chattanooga, our Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and Transcranial Magnetic Stimulation (TMS) treatments are grounded in cutting-edge neuroscience and designed to help patients and referring providers better understand how to harness ketamine’s neuroplastic potential.
If you’re interested in learning more about science-informed approaches that look beyond symptom-only models, we invite you to reach out to explore whether our services may be appropriate for your needs.
Founded in 2019, Scenic City Neurotherapy is at the forefront of advanced and comprehensive treatments for those facing treatment-resistant conditions. Our mission is to optimize brain function and elevate well-being through cutting-edge therapies. We specialize in two pioneering approaches: Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and Transcranial Magnetic Stimulation (TMS).
If you are exploring innovative solutions for mental health, chronic pain, and other neuro-degenerative conditions, Scenic City Neurotherapy offers transformative treatment options. Join us in leading the charge towards groundbreaking brain optimization treatments and empowering individuals to reclaim their lives.
If you’re ready for treatment that’s built on proof, not trial and error, contact us today.
📞 (423) 228-0579
By Charles Miller, CRNA, CMO, Founder/Owner of Scenic City Neurotherapy
If you’ve recently started an anti-depressant like Prozac, you may have the same question many others have asked. GoodRX notes that many people begin to feel early improvements within the first 1–2 weeks of starting fluoxetine (Prozac), but full mood-related benefits typically take 4–6 weeks or longer to emerge. Some individuals require up to 8–12 weeks for the medication to reach its full effect, and response varies by condition and individual biology.
Some people experience symptom relief yet still feel flat, unmotivated, or disconnected from themselves. That doesn’t mean you failed the medication or that you are treatment-resistant. It may mean the current approach is relieving certain symptoms without fully supporting how your brain functions day to day.
At Scenic City Neurotherapy, our approach starts by clarifying whether treatment is helping you move toward the quality of life you’re actually aiming for, not just away from symptoms.
Prozac is an antidepressant in the SSRI (selective serotonin reuptake inhibitor) class. It’s commonly prescribed for depression, anxiety, obsessive-compulsive disorder (OCD), eating disorders, panic disorder, and depressive episodes associated with bipolar disorder.
SSRIs work by increasing serotonin availability in the brain. For some individuals, this is associated with reductions in emotional intensity, intrusive thoughts, or persistent low mood. Large-scale studies show that a portion of people improve, while others report only partial relief.
Research such as the STAR*D study found that:
These findings highlight the variability in antidepressant response and suggest that depression is influenced by multiple factors beyond neurotransmitter levels alone.
At Scenic City Neurotherapy, our treatments focus on supporting how the brain’s networks communicate and adapt, offering an approach that targets neural function rather than neurotransmitter availability alone.
Individual responses vary, but clinical literature describes a general pattern in how Prozac and other SSRIs are experienced over time.
It’s important to note that response timelines vary, and continued time on a medication does not consistently produce additional benefit for every individual.
When symptom relief is limited, it may be helpful to look beyond neurochemical changes alone. Our approach includes brain-focused therapies such as Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and Transcranial Magnetic Stimulation (TMS), which focus on how brain networks are functioning and communicating, offering additional pathways for people who have not found adequate relief through medication.
If Prozac reduces symptoms but you still feel disconnected, unmotivated, or emotionally flat, it may not be fully aligned with your goals.
Many people remain on Prozac because:
But manageable isn’t always the same as fulfilling.
These experiences are common, yet rarely addressed effectively. In many cases, they reflect a situation where symptoms are reduced, but the brain patterns that influence behavior, resilience, and emotional flexibility are not fully supported.
At Scenic City Neurotherapy, our approach supports neural pathways for better adaptability, emotional range, mental clarity, and resilience, not just symptom suppression.
Before switching medications, it can be helpful to pause and assess whether the current approach is targeting what’s actually driving your symptoms, rather than only managing how they show up.
You might find it useful to reflect on questions such as:
Switching medications can be appropriate in certain situations. In other cases, multiple medication changes occur without a broader reassessment of treatment goals or underlying contributors to symptoms.
A reassessment at this stage may include:
Brain-focused therapies are often considered at this decision point, when individuals are weighing whether to continue, adjust, or explore alternatives to their current treatment.
Brain-focused therapies such as our Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and Transcranial Magnetic Stimulation (TMS) are not guarantees or replacements for everyone. They are tools designed to support brain function differently than daily medication alone.
Some patients report changes in mood, stress tolerance, or cognitive flexibility, while others notice different effects. Individual responses vary, and outcomes cannot be predicted.
At Scenic City Neurotherapy, these options are offered within a structured evidence-based treatment protocol that emphasizes patient safety, comfort, and education.
If symptoms are reduced but your quality of life still feels limited, or you hesitate to hope for more, that’s worth paying attention to. Success of a medication should be defined by your goals, not just symptom checklists.
At Scenic City Neurotherapy, our approach focuses on understanding whether your brain is being supported in ways that align with those goals, not just whether symptoms are quieter.
No. Often it reflects a mis-matched approach rather than a permanent condition. Re-evaluating how treatment targets the brain can offer new options.
Yes. Most patients begin our treatments while staying on their current medications. Sudden medication adjustments can trigger significant withdrawal symptoms, which can interfere with treatment and overall stability.
At Scenic City Neurotherapy, no medication or lifestyle changes are made during stabilization. This ensures we can clearly distinguish what improvements are a result of the treatment, not from withdrawal or medication shifts.
As you begin to improve, you can work with your prescriber to gradually and safely taper medications if appropriate. The goal is clarity, safety, and stable progress.
Prozac is helpful for some individuals, while others report uncertainty, partial relief, or ongoing questions about whether the level of improvement meets their personal goals. Experiences vary, and there is no single “right” response to treatment.
If you find yourself questioning whether Prozac is meeting your needs, that question can be part of a broader, thoughtful evaluation of treatment options.
At Scenic City Neurotherapy, our treatments focus on brain function and individual goals. Together, we can evaluate whether they are appropriate to consider before, alongside, or beyond medication.
At Scenic City Neurotherapy, we help people find real answers and lasting relief through advanced, evidence-based treatments designed to address the root of mental health and chronic pain challenges, not just the symptoms.
Founded in 2019 by Charles Miller, CRNA, our clinic leads the way in Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and Transcranial Magnetic Stimulation (TMS) – two cutting-edge therapies proven to safely and effectively restore healthy brain communication.
Our approach is evidence-backed, informed by research, and focused on helping you feel clear, resilient, and capable of moving forward.
If you’re ready for treatment that’s built on proof, not trial and error, contact us today.
📞 (423) 228-0579
By Charles Miller, CRNA, CMO, Founder/Owner of Scenic City Neurotherapy
In-clinic ketamine, specifically Minimally Stimulated Ketamine Infusion Therapy (MSKIT®), is generally regarded as safer, more controlled, and more clinically consistent than at-home ketamine.
At-home ketamine carries high risks of misuse (55% report accidental or intentional overuse), life-threatening events, inconsistent outcomes, and no medical supervision or emergency response. In contrast, in-clinic IV ketamine therapy provides precise dosing, continuous medical monitoring, and evidence-based protocols that are designed to mitigate risk and lead to reproducible, long-term outcomes.
Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) was designed to minimize stimulation, optimize dosing, and support long-term neuronal regrowth. This protocol directly addresses every risk that makes at-home ketamine unpredictable and unsafe.
At-home ketamine is typically taken as lozenges or tablets, shipped after a brief telehealth evaluation.
This model often emphasizes convenience, which may come at the expense of patient safety or treatment success.
In-clinic ketamine therapy, specifically Minimally Stimulated Ketamine Infusion Therapy (MSKIT®), uses IV administration, after a thorough intake process with our Care Team.
This protocol produces mappable, measurable neurological changes, which are difficult to replicate at home.
Source: Psychiatric Times
This misuse increases the risk of severe side effects, including respiratory depression and elevated blood pressure.
In contrast, MSKIT® uses optimal dosing tailored to your unique needs and infrequent administration, eliminating the possibility of self-misuse entirely.
The FDA warns against the use of compounded ketamine products without supervision of:
Source: FDA
In-clinic ketamine therapy directly addresses every one of these risks through:
Died due to the effects of ketamine while sitting in a hot tub at home – no controlled environment, no supervision, no monitoring.
Source: New York Post
This case shows how misjudgments at home can have fatal consequences.
Chronic unsupervised ketamine use led to debilitating pain, bladder dysfunction, and death at age 20.
Source: The Scottish Sun
These incidents further emphasize why MSKIT® exists: to administer ketamine safely, predictably, and ethically.
It’s crucial to share insights from those who have firsthand experience with at-home ketamine use. In our blog, we present testimonials compiled by our Care Team, who have listened to and documented the experiences of individuals undergoing at-home ketamine therapy.
Ethical medical professionals advocate for the following guidelines:
MSKIT® at Scenic City Neurotherapy follows these clinical recommendations exactly, which is why in-clinic ketamine therapy produces far superior and safer outcomes than any at-home model.
| Variable | At-Home Ketamine | In-Clinic Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) |
| Dosing Precision | Low | Exact, controlled, IV titration |
| Safety Monitoring | None | Continuous medical monitoring |
| Neuroplastic Benefit | Limited and inconsistent | Evidence-based psychoplastogenic treatment |
| Risk of Misuse | High (55% misuse) | Zero – clinician administered |
| Adverse Event Response | None | Immediate medical intervention available |
| Long-term Outcomes | Variable | Clinically reproducible results |
At-home ketamine may create temporary relief for some people, but it may not consistently replicate the neurological benefit and long-term clinical outcomes of MSKIT® as administered at Scenic City Neurotherapy in Chattanooga, TN.
Ketamine is not just a medication. It’s a treatment process. Just like one chemotherapy treatment cannot reverse cancer, one ketamine infusion may not create the neural changes necessary for long term healing.
Yale’s Department of Psychiatry has shown that a series of six infusions over three weeks increases neuroplasticity in most patients. By delivering infusions as a structured series, patients may progressively rebuild neural pathways and strengthen healthier brain circuits.
Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) is a medically supervised treatment process. The therapeutic outcome depends on:
MSKIT® was designed so that each variable is key to reaching and maintaining therapeutic blood levels, widely considered as essential for treatment success and comfort.
When people look up “in-clinic vs at-home ketamine,” they’re trying to understand: Is the convenience worth the risk?
The evidence says: the risks and benefits should be carefully considered.
At-home ketamine carries higher risks of misuse, life-threatening events, addiction, and medical complications.
In contrast, Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) provides an ethical, safe, and effective approach rooted in evidence and science.
This is why patients travel to Scenic City Neurotherapy from across the country. They want structured results and medically supervised care, not risks.
Short answer: It carries higher risks compared to medically supervised administration. At-home ketamine has high misuse rates (55%), no monitoring, and elevated risk of life-threatening events. In-clinic ketamine infusion therapy eliminates these risks through controlled dosing, continuous monitoring, and immediate clinical support during administration.
Short Answer: Yes, several telehealth companies prescribe ketamine lozenges for at-home use, typically after a brief virtual evaluation. But these services do not provide continuous monitoring, controlled dosing, or immediate clinical support during administration, which is statistically documented to increase risk.
Telehealth platforms often rely on compounded ketamine shipped directly to the patient. The FDA has specifically warned against this model due to risks of sedation, dissociation, unpredictable reactions, and potential for misuse when ketamine is taken without medical supervision.
Because of these safety gaps, evidence-based clinics like Scenic City Neurotherapy do not offer at-home ketamine. Instead, we use Minimally Stimulated Ketamine Infusion Therapy (MSKIT®), a controlled, in-clinic protocol designed to prioritize comfort, expertise, education and evidence – all essential for safe and effective treatment.
Short Answer: Most at-home ketamine providers rely on telehealth check-ins, prewritten guidance, and post-session surveys, but they do not provide real-time safety monitoring during ketamine administration, which is when most complications occur.
Typical at-home “safety measures” include:
While these steps may offer basic support, they do not prevent the most documented risks of at-home ketamine:
In contrast, Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) ensures patient safety through:
This level of supervision is what makes in-clinic treatment significantly safer and more predictable than unsupervised at-home models.
Short Answer: From a medical perspective, the safest way to use ketamine therapy at home is not to use it at home at all. The FDA and multiple clinical sources warn that unsupervised ketamine use dramatically increases the risk of misuse, adverse reactions, and long-term complications.
No at-home precautions can replace real-time medical supervision. The high rate of misuse (55%) and documented cases of overdose and medical complications highlight the limitations of harm reduction in unsupervised environments.
This is why Scenic City Neurotherapy in Chattanooga, TN uses Minimally Stimulated Ketamine Infusion Therapy (MSKIT®), which delivers ketamine in a medically monitored setting designed to support reproducible results without exposing patients to the dangers associated with self-administered ketamine.
At Scenic City Neurotherapy, we help people find real answers and lasting relief through advanced, evidence-based treatments designed to address the root of mental health and chronic pain challenges, not just the symptoms.
Founded in 2019 by Charles Miller, CRNA, our clinic leads the way in Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and Transcranial Magnetic Stimulation (TMS) – two cutting-edge therapies proven to safely and effectively restore healthy brain communication.
Our approach is evidence-backed, informed by research, and focused on helping you feel clear, resilient, and capable of moving forward.
If you’re ready for treatment that’s built on proof, not trial and error, contact us today.
📞 (423) 228-0579
By Charles Miller, CRNA, CMO, Founder/Owner of Scenic City Neurotherapy
Zoloft can help reduce anxiety for some people. However, some continue to experience symptoms or side effects because their anxiety isn’t caused by a serotonin imbalance. For them, it may be rooted in poor or disrupted brain communication.
This is why patients who don’t feel better on Zoloft often respond more effectively to brain-based treatments like Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) at Scenic City Neurotherapy, which is designed to support healthier neural communication.
Zoloft is a selective serotonin reuptake inhibitor (SSRI). Its primary action is to increase serotonin availability between neurons. But serotonin is only one small part of how the brain regulates itself. Anxiety is driven by:
Zoloft modifies chemistry, but it may not address all aspects of these neural communication patterns, which is why:
This is the gap Scenic City Neurotherapy fills by focusing on treatments that support improved brain communication through Minimally Stimulated Ketamine Infusion Therapy (MSKIT®).
When taking Zoloft for anxiety, it usually takes 6–12 weeks to create measurable anxiety improvement, and many people feel worse before they feel better.
SSRIs are slow because:
For someone already experiencing anxiety, waiting 2–3 months isn’t impossible, but it can feel discouraging or difficult. You shouldn’t have to hold out that long when faster, more effective options exist. Many of our patients at Scenic City Neurotherapy specifically sought us out because they don’t want to wait another three months to see if something might work.
| Treatment | Expected Timeline | What Patients Commonly Report |
| Zoloft (SSRI) | 6–12 weeks for improvement | Early anxiety spike, emotional blunting, insomnia, uncertain benefit |
| Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) at Scenic City Neurotherapy | Some patients report noticeable changes within hours to days | Mental clarity, reduced rumination, improved regulation |
Again, this is why people travel to Chattanooga for mental health care. Patients often describe the results as tangible and timely.
The most common Zoloft side effects include nausea, fatigue, insomnia, emotional blunting, and sexual dysfunction – many of which cause patients to discontinue the medication or seek other treatment options like ketamine infusion therapy.
This is why many patients turn to brain-based treatments that don’t force them to feel worse first in the hope they might eventually improve.
If taking Zoloft for anxiety isn’t helping, it does NOT mean you’re resistant to treatment. It means the root issue may involve more than serotonin alone, including how different brain regions communicate.
Scenic City Neurotherapy’s approach is built precisely for you.
Chronic anxiety develops when:
SSRIs may not fully rewire these circuits. MSKIT® is designed to support neuroplasticity more directly.
Ketamine has been shown to boost neuroplasticity, helping your brain build healthier communication pathways. This is what allows people to finally break long-standing cycles like:
This is the core of Scenic City Neurotherapy’s treatment: Support healthier communication, and symptoms may begin to change.
Modern alternatives focus on brain health, not a chemical imbalance. One evidence-based option for anxiety is Ketamine Infusion Therapy delivered in a medical environment like Scenic City Neurotherapy.
Ketamine works by:
Unlike daily medication:
Most Scenic City Neurotherapy patients report:
People travel to Chattanooga for this care because the outcomes, protocol, and safety standards are highly structured and patient-focused.
Ketamine Infusion Therapy is a strong fit for those seeking a brain-based approach to mental health. Whether you’ve tried medications in the past or you’re exploring treatment for the first time, ketamine provides an evidence-based alternative to traditional trial-and-error approaches.
Scenic City Neurotherapy specializes in helping individuals who want an effective, evidence-based path forward, whether it’s their first treatment or their next step.
From our clinical experience:
Scenic City Neurotherapy exists for people exactly like this – those who’ve tried everything and need something built around brain health instead of chemical guesswork.
You can expect a structured, medically supervised, education-first process that ensures safety, support, and measurable results.
This is the opposite of “take this pill and wait a few months.” It is active brain health treatment, and it is why our patients see real change.
The best treatment for anxiety is one that improves the brain’s communication pathways, not just its chemistry. Research shows that neuroplasticity-based treatments, such as Ketamine Infusion Therapy, may offer more meaningful results than traditional medications for many people.
No. You should not stop Zoloft before beginning ketamine therapy unless your prescribing clinician directs you to. Most patients continue their current medication throughout treatment to maintain stability and avoid withdrawal symptoms.
At Scenic City Neurotherapy, no medication adjustments are made during the Stabilization phase (the first infusion series). This ensures:
This approach protects your stability while giving us the cleanest possible clinical read on your progress.
Neither Prozac nor Zoloft for anxiety is universally “better.” They work similarly, and effectiveness varies from person to person. Both are SSRIs, both require 6–12 weeks to show benefit, and both can cause emotional blunting or other side effects. For many people, the bigger issue is that SSRIs may not fully address all underlying brain communication problems associated with anxiety.
This is why so many individuals ultimately look for alternatives like Ketamine Infusion Therapy at Scenic City Neurotherapy, where treatment focuses on neuroplasticity and restoring how the brain communicates – areas SSRIs cannot do.
If Zoloft for anxiety isn’t helping, or if the side effects outweigh the benefits, it doesn’t mean you’re out of options. It means you need a modern, brain-based approach that aligns with how anxiety actually works.
Scenic City Neurotherapy provides evidence-based treatments built on:
You don’t have to try endless things before choosing a modern option. You can reclaim your quality of life now.
At Scenic City Neurotherapy, we help people find real answers and lasting relief through advanced, evidence-based treatments designed to address the root of mental health and chronic pain challenges, not just the symptoms.
Founded in 2019 by Charles Miller, CRNA, our clinic leads the way in Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and Transcranial Magnetic Stimulation (TMS) – two cutting-edge therapies proven to safely and effectively restore healthy brain communication.
Our approach is evidence-backed, informed by research, and focused on helping you feel clear, resilient, and capable of moving forward.
If you’re ready for treatment that’s built on proof, not trial and error, contact us today.
📞 (423) 228-0579
By Charles Miller, CRNA, CMO, Founder/Owner of Scenic City Neurotherapy
Lexapro often stops working because it adjusts serotonin levels, not the neural connectivity issues that drive depression, anxiety, and emotional dysregulation. When the underlying pathways remain disrupted, symptoms return, even if the medication worked at first. Clinicians sometimes call this loss of effectiveness “antidepressant tachyphylaxis,” or “SSRI poop-out.”
SSRIs like Lexapro can be beneficial for many people, especially when prescribed by qualified professionals during early or moderate depression or anxiety. However, if symptoms persist or return, a different therapeutic approach may be indicated.At Scenic City Neurotherapy in Chattanooga, we see this often. Many patients come in after their SSRI did not meet their expectations, whether holding them in a place they do not want to be in or never working at all. When this happens, it doesn’t mean symptoms are treatment-resistant. It means your brain likely needs an approach that supports neural connectivity, not just chemistry.
Our ketamine infusion protocols are delivered by CRNAs with extensive anesthesia experience, and are informed by clinical practice and ongoing outcomes tracking.
Lexapro (escitalopram) is an antidepressant that belongs to a group of medicines known as selective serotonin reuptake inhibitors (SSRIs).
Its primary action:
This approach may help some individuals temporarily, but it is not designed to repair the neural networks impaired by chronic stress, trauma, or overload – the very networks that treatments like Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) at Scenic City Neurotherapy are built to restore.
Research has repeatedly shown that the chemical imbalance theory is incomplete, and in many cases, incorrect. A landmark umbrella review found no consistent evidence that serotonin deficiency causes depression (Moncrieff et al., 2022).
This is the story we hear again and again when patients finally reach us:
This happens because Lexapro does not stimulate neuroplasticity, your brain’s ability to reorganize its pathways and create new connections.
When neural networks are:
…no amount of serotonin-adjusting medication will reconnect them.
That’s why so many patients at Scenic City Neurotherapy – especially those who’ve tried multiple antidepressants – see rapid improvement once they start treatments that directly target brain communication, like Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and TMS.
(Case summaries derived from publicly shared patient stories at Scenic City Neurotherapy. Individual results vary, and patient experiences reflect personal outcomes under medical supervision.)
Before:
“I was over medicated on about 10+ different prescriptions. I was depressed, anxious, traumatized, suicidal, and just completely lost and helpless.”
After MSKIT®:
“I went through the six therapy infusion treatments, and they not only changed my life, they saved my life as well. After the treatments were finished and some time went by, I was finally able to move throughout life again like a normal person again. I was able to get off 6+ medications, get a new job, & LIVE again.”
Before:
“My family and I were desperately looking for relief from my anxiety and deep depression. I was on depression medication, and it wasn’t working. I was directed by my primary care physician to try a different drug. It was a disaster. My brain felt like it was fried.”
After MSKIT®:
“The first three treatments gave me a glimpse at what the future held. I was finally hopeful. The next treatments showed vast improvement!! I went from biweekly infusions to monthly. My last infusion was almost 2 months ago and under the guidance from the SCN staff and my psychiatrist I went on an as-needed basis. I felt like the treatment cleansed my brain. No more fog or suicidal ideation.”
Before:
“I’ve had OCD since I was a child; anxiety, social anxiety, and depression since I was a teenager. The past 6-7 years, it really started to affect people around me. I suffered from treatment-resistant depression for quite some time. I have taken several types of medication over the years. I mean, life was difficult…
I chose Scenic City because I was at the end, I feel, of my journey in a sense for medications, antidepressants, mood stabilizers. They were not helping.”
After MSKIT®:
“Since I’ve experienced treatment, I am happier overall. I think it’s a pretty significant difference. I feel better about things. How I deal with situations – the optimism is there. I am happy that I am living more in the present instead of worrying and thinking about the future. I am able to experience life in a different way.”
These cases reflect a consistent pattern:
Once neural communication is restored, patients finally make progress SSRI adjustments never delivered.
Learn how other patients describe their results on our website.
If your symptoms are driven by disrupted neural pathways, SSRIs alone cannot fix the root issue. This is the most common reason people feel stuck.
At Scenic City Neurotherapy, we specialize in two evidence-based approaches:
Increases neuroplasticity, giving your brain the capacity to:
Why it matters:
Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) supports long-term healing because it does what SSRIs may not. It repairs the system, not just the symptoms.
TMS uses magnetic pulses to stimulate underactive brain regions involved in mood regulation. It:
For many, whether together or separate, TMS and Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) are what finally restores a sustainable baseline.
Use this checklist as guidance:
If you’re nodding “yes,” your brain likely needs brain-focused care, not another chemical adjustment.
If these patterns sound familiar, you may benefit from learning more about why antidepressants often fall short. We break this down further here.
Our approach is different because it’s built on:
By adhering to this approach, we help you achieve the best results and take back your quality of life.
At Scenic City Neurotherapy, we prioritize science-backed treatments that target the root causes of mental health challenges and chronic pain, not just the symptoms. Patients from all over the country choose our Chattanooga clinic for care they can trust.
Not necessarily. Dose increases may temporarily improve symptoms, but they rarely produce long-term results when the root issue is neural connectivity. Before increasing medication, consider a no-cost consultation for brain-focused treatments like Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) at Scenic City Neurotherapy in Chattanooga, TN.
Yes. Most patients begin ketamine therapy while staying on their current medications. Sudden medication adjustments can trigger significant withdrawal symptoms, which can interfere with treatment and overall stability.
At Scenic City Neurotherapy, no medication or lifestyle changes are made during stabilization. This ensures we can clearly distinguish what improvements are a result of the ketamine therapy, not from withdrawal or medication shifts.
As you begin to improve, you can work with your prescriber to gradually and safely taper medications if appropriate. The goal is clarity, safety, and stable progress.
Stopping suddenly can cause significant withdrawal. This is why we collaborate closely with your prescriber.
If Lexapro has stopped working, it does not mean you’ve run out of options. It means your brain needs something that restores communication, not just chemistry.
At Scenic City Neurotherapy, we help patients rebuild a healthy baseline using advanced treatments that repair the neural pathways medications cannot.
If you’re ready for a new direction, our team is here to support your next step.
Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2022). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01661-0
At Scenic City Neurotherapy, we help people find real answers and lasting relief through advanced, evidence-based treatments designed to address the root of mental health and chronic pain challenges, not just the symptoms.
Founded in 2019 by Charles Miller, CRNA, our clinic leads the way in Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and Transcranial Magnetic Stimulation (TMS) – two cutting-edge therapies proven to safely and effectively restore healthy brain communication.
Our approach is evidence-backed, informed by research, and focused on helping you feel clear, resilient, and capable of moving forward.
If you’re ready for treatment that’s built on proof, not trial and error, contact us today.
📞 (423) 228-0579
By Charles Miller, CRNA, CMO, Founder/Owner of Scenic City Neurotherapy
At times, we’ll speak with a patient who asks, “Does ketamine help fibromyalgia?” It’s asked frequently enough that writing a full article on the question seemed appropriate.
For many patients, the answer is “yes.” Ketamine therapy helps fibromyalgia by modulating the inappropriate pain signaling that drives daily symptoms.
Fibromyalgia is often described as the brain sending an exaggerated inflammatory response to the body without a current physical cause. This is typically seen as secondary to long-term stress, overwhelm, or physical overexertion. This can lead to symptoms like sleep disruption, cognitive fog, fatigue, and chronic, widespread pain.
With Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) at Scenic City Neurotherapy, we focus on restoring the brain’s communication networks so the pain signaling system can recalibrate. This approach can support improved pain regulation, sharper thinking, and better function day to day.
Ketamine improves fibromyalgia symptoms by targeting what may be the root of the problem: central sensitization. This is the process where the brain becomes hypersensitive and interprets normal sensory input as pain.
Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) is specifically designed to leverage ketamine’s neurological effects in a controlled, low-stimulation environment so the brain can begin to reset abnormal pain processing effectively and safely – in a medically supervised setting.
Every infusion at Scenic City Neurotherapy is delivered using our treatment protocol, which can minimize stimulation and non-inflammatory pain. This symptomatic relief is welcomed by patients with fibromyalgia who often have overwhelmed nervous systems. Our protocol is built to support nervous system regulation and stimulate neuroplasticity.
Drawing from our internal patient cases:
Every patient responds differently. Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) may create the conditions for meaningful change, and we’ll study how your system responds once we get started together.
You can explore additional patient stories on our website.
Traditional fibromyalgia treatments often fail because they treat symptoms, not the neurological cause. Ketamine helps because it directly influences the brain systems that are involved in generating chronic pain signals.
Most patients come to Scenic City Neurotherapy after trying:
These options may help temporarily, but they rarely rewire the brain’s pain pathways. Ketamine differs from traditional treatments by directly addressing the pain-processing pathways instead of simply masking symptoms.
This is why, for many patients, pain improvement may continue after Stabilization ends. This depends on individual response, coupled with ongoing medical support. You’ll also have booster infusions available as a tool whenever you need additional support.
For a clear explanation, you can watch Charles Miller walk through how ketamine interrupts fibromyalgia pain signaling in this short video.
Patients can expect a calm, private, medically supervised infusion designed to minimize stimulation and maximize neurological benefit.
At Scenic City Neurotherapy in Chattanooga, TN, each ketamine infusion for fibromyalgia includes:
Every part of our ketamine treatment protocol is designed to optimize the neurological effects of ketamine while keeping the patient comfortable and safe.
For many individuals, symptoms may become more manageable, flares less frequent, and daily function improved. In some cases, patients have reported pain resolution that approached the point of remission. Your individual results depend on the severity of your symptoms and the habits that support your healing.
Our internal patient data shows:
Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) helps create the neurological foundation, and daily choices help shape and maintain that change.
A: It can. Ketamine can reduce widespread pain by calming overactive pain pathways. Chronic widespread pain in fibromyalgia is largely neurological. Our approach may reduce central sensitization, giving the brain the capacity to rewire and interpret signals more accurately.
Learn more about how ketamine therapy supports long-term relief from chronic pain on our website.
A: Your brain never reaches deep sleep. Fibromyalgia keeps the nervous system overstimulated, causing light, disrupted sleep and constant fatigue. Our protocol is designed to help the brain regulate more effectively, which can improve sleep and reduce exhaustion.
A: Yes. Ketamine is considered safe for fibromyalgia when delivered IV at subanesthetic doses under proper medical supervision. At Scenic City Neurotherapy, anesthesia-trained providers administer each infusion using our MSKIT® protocol, emphasizing education, accurate dosing, continuous monitoring, and measurable clinical outcomes.
A: Yes. Ketamine may be a more effective long-term option for many patients because it reduces pain sensitivity, while opioids increase it over time.
Long-term opioid use often leads to Opioid Induced Hyperalgesia – a condition where the nervous system becomes more sensitive to all stimuli. The pain isn’t necessarily worsening; the brain’s interpretation of pain becomes amplified, so discomfort feels more intense the longer opioids are used.
MSKIT® works differently. It restores communication in the brain’s pain-processing networks by:
These factors make this approach effective for fibromyalgia and other neuropathic pain conditions such as Complex Regional Pain Syndrome (CRPS) and phantom limb pain.
Many of our patients report experiencing significant improvement or even remission, with better day-to-day function and fewer flares – outcomes opioids rarely achieve because they do not repair the nervous system.
As with any medical treatment, individual responses may vary. In addition, personal outcomes depend on factors like the severity of symptoms and overall health.
For a deeper explanation, you can also watch our short video on why opioids increase pain sensitivity and how ketamine resets the system. Watch our explanation here
Ketamine therapy offers a powerful opportunity for fibromyalgia treatment because it treats the neurological root of your chronic pain.
At Scenic City Neurotherapy, our Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) protocol enhances ketamine’s effectiveness by minimizing stimulation, maximizing neurological benefits, and supporting nervous system regulation.
If you’re looking for a treatment backed by science, real outcomes, and a patient-first model, MSKIT® may be the missing piece in your fibromyalgia care.
Littlejohn G, Guymer E. Modulation of NMDA Receptor Activity in Fibromyalgia. Biomedicines. 2017 Apr 11;5(2):15. doi: 10.3390/biomedicines5020015. PMID: 28536358; PMCID: PMC5489801.
Founded in 2019, Scenic City Neurotherapy is at the forefront of advanced and comprehensive treatments for those facing treatment-resistant conditions. Our mission is to optimize brain function and elevate well-being through cutting-edge therapies. We specialize in two pioneering approaches: Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and Transcranial Magnetic Stimulation (TMS).
If you are exploring innovative solutions for mental health, chronic pain, and other neuro-degenerative conditions, Scenic City Neurotherapy offers transformative treatment options. Join us in leading the charge towards groundbreaking brain optimization treatments and empowering individuals to reclaim their lives.
Contact Founder and Chief Medical Officer, Charles Miller today to learn more about our evidence-informed protocols for Minimally Stimulated Ketamine Infusion Therapy (MSKIT®). Call (423) 228-0579 or visit www.ScenicCityNeuro.com.
